Kura Oncology Earnings
NASDAQ: KURAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Tue, Nov 3, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.83
Kura Oncology earnings summary
Kura Oncology is scheduled to report Sep/2026 earnings on Nov 3, 2026, with analysts expecting EPS of $-0.83. In its most recent report on Aug 12, 2026 (Q2 2026), KURA posted EPS of $-0.77. Revenue for the quarter was $20.9 million.
Across the last 16 reports, KURA shares moved an average of 8.9% (in either direction) in the first trading session after results, rising 10 times and falling 6 times.
Summary generated from market data by MetaCap's automated system. Methodology
KURA earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 12, 2026 | — | $-0.77 | — | +9.5% |
| May 12, 2026 | — | $-0.83 | — | +22.0% |
| Mar 5, 2026 | — | $-0.92 | — | -3.5% |
| Nov 4, 2025 | — | $-0.85 | — | +13.6% |
| Aug 7, 2025 | — | $-0.75 | — | +32.5% |
| May 1, 2025 | — | $-0.66 | — | -11.0% |
| Feb 28, 2025 | — | $-0.21 | — | -2.3% |
| Nov 7, 2024 | — | $-0.63 | — | -10.0% |
| Aug 8, 2024 | — | $-0.59 | — | +1.5% |
| May 2, 2024 | — | $-0.59 | — | +0.4% |
| Feb 27, 2024 | — | $-0.55 | — | +9.0% |
| Nov 2, 2023 | — | $-0.50 | — | -5.4% |
| Aug 9, 2023 | — | $-0.53 | — | -11.3% |
| May 10, 2023 | — | $-0.50 | — | +5.0% |
| Feb 23, 2023 | — | $-0.49 | — | +0.6% |
| Nov 3, 2022 | — | $-0.53 | — | +4.8% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.